Table 6.
Characteristics of behavioural ADE reports to ICS in Denmark from 2009 to 2019
| Incidence | |
|---|---|
| N (total) = 3 | |
| Drugs | |
| Beclomethasone | – |
| Budesonide | 2 |
| Ciclesonide | – |
| Fluticasone | 1 |
| Mometasone | – |
| Sex | |
| Male | 3 |
| Female | – |
| Age | |
| 0–9 years | 2 |
| 10–19 years | 1 |
aCharacteristics of reports made by healthcare professionals to the Danish Medicines Agency database of adverse drug events (DKMA). The Danish Medicines Agency has confirmed to the authors that, despite small cell sizes, reporting these public data are in accordance with all Danish regulations and EUs General Data Protection Regulation (GDPR)